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Abstract
Production of the pro-inflammatory cytokine IL-12 by innate phagocytes drives the differentiation of IFN-c-producing
effector T cells during Toxoplasma gondii infection. However, the role of IL-12 in the regulation of memory CD8+ T cell
differentiation and function during murine toxoplasmosis is unclear. To track memory CTL development, we identified a
novel H-2K
b-restricted CTL population specific for the Toxoplasma antigen tgd057. Tgd057-specific CTLs were induced by
both vaccination and natural peroral infection, and were representative of the polyclonal CTL population. Tgd057-specific
primary effector cells required IL-12 for the differentiation of KLRG1+ effector subpopulations and IFN-c production in
response to restimulation with parasite-infected cells, but not to restimulation with cognate peptide. The effect of IL-12
deficiency during the primary response was profoundly imprinted on memory CTLs, which continued to show defects in cell
numbers, KLRG1+ effector memory subpopulation differentiation, and IFN-c recall responses. Importantly, isolated CD62L
hi
KLRG1- CD8+ T cells differentiated in the absence of IL-12 were enhanced in their ability to generate IFN-c-producing
secondary tgd057-specific effector cells. Our data, for the first time, demonstrate the negative impact of IL-12 signaling on
the quality of the central memory CTL compartment. Thus, despite the beneficial role of IL-12 in promoting effector
differentiation, excessive exposure to IL-12 during CTL priming may limit the development of long-term protective
immunity through the decreased fitness of central memory CTL responses.
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Introduction
Infection by the intracellular protozoan parasite Toxoplasma
gondii causes severe disease in immunocompromised individuals
including neonates, transplant recipients, and people with AIDS
[1]. In healthy individuals however, resistance to toxoplasmosis is
mediated by the ability of T lymphocytes to produce the essential
effector cytokine IFN-c [2,3]. Although both innate and adaptive
immunity synergize to combat parasitic infection [4,5], CD8+ T
cells are known to be the main mediator of protective immunity
[6,7,8,9]. The importance of CTL responses is exemplified by the
differential susceptibility of inbred strains of mice to toxoplasmic
encephalitis, where resistant strains are protected by CTLs
responding to antigens presented by H-2L
d MHC class I products
[10]. Unfortunately, the natural Toxoplasma epitopes that drive
CTL activation remain incompletely defined and thus encumber
our ability to track the development of Ag-specific CTLs.
The Toxoplasma antigens historically identified as CTL targets
were defined by the vaccination of mice with purified antigens or
DNA expression vectors. The T. gondii surface antigen SAG1 (p30)
was the first isolated Ag shown to elicit CTL effector responses
[11] and protective immunity in mice [12]. SAG1 DNA
vaccination also protected mice from lethal parasite challenge
[13]. DNA vaccination using the secreted Toxoplasma proteins
GRA1, GRA7, and ROP2 also elicits partially protective
immunity [14,15]. Nonetheless, the precise CTL-specific peptide
epitopes derived from these candidate antigens have yet to be
identified. Recently, an unbiased epitope discovery screen
identified a single H-2L
d-restricted, GRA6 epitope-specific CTL
population elicited by T. gondii infection in BALB/c mice [16].
Although these CTLs were argued to be an immunodominant
population, another report has emerged describing two H-2L
d-
restricted CD8+ T cell populations specific for the GRA4 and
ROP7 T. gondii antigens [17]. The latter study utilized caged
MHC class I tetramers that allow the exchange of a conditional
ligand occupying the MHC molecule for putative antigenic
epitopes (pre-selected by a targeted epitope prediction program),
and subsequently used large numbers of freshly generated
tetramers to screen for Ag-specific CTLs [18]. Since both of these
studies involved mice of the H-2
d haplotype, and most basic
PLoS Pathogens | www.plospathogens.org 1 March 2010 | Volume 6 | Issue 3 | e1000815immunological research uses C57BL/6 mice of the H-2
b
haplotype [19], we chose to screen for putative Toxoplasma CTL
epitopes in C57BL/6 mice. Using caged MHC class I tetramers,
we identified a single genuine H-2K
b-restricted epitope derived
from the protein tgd057.
Having identified a novel population of Toxoplasma-specific
CD8+ T cells, we sought to extend our previous findings regarding
the role of IL-12 for the differentiation of effector and memory
CTLs. T. gondii infection induces a robust type 1 polarized immune
response marked by the production of the pro-inflammatory
cytokine IL-12 by macrophages and dendritic cells [20]. It is clear
that in CD4+ TH1 cells, IL-12 signaling is required for the
activation of IFN-c production [21]. However in CD8+ T cells,
the impact of IL-12 signaling on effector and memory responses to
viral, bacterial, and parasitic infections has only recently come to
light. We have previously shown that among the polyclonal CTL
populations induced after T. gondii vaccination, IL-12 is strictly
required for IFN-c production and KLRG1+ effector subpopu-
lation differentiation in vivo [22]. KLRG1 expression in CD8+ T
cells is thought to mark replicative senescence in a subset of highly
activated CTLs [23,24,25]. Furthermore, IL-12 can induce
KLRG1 through the activation of T-bet, a master regulator of
the type 1 immune program [26]. Therefore, it is thought that
primary pathogen challenge induces KLRG1 in IL-12-sensitive
CD8+ T cells that, while being highly activated effector cells, are
short-lived and do not contribute to secondary memory responses.
As a consequence of the effector program initiated by IL-12
signaling during primary CTL activation, memory precursor CTL
development may be negatively impacted. IL-12 deficiency was
shown to increase memory CTL precursor frequency in the
primary response to L. monocytogenes and LCMV [26,27], and to
impart superior immunity to bacterial re-infection [27]. Unlike
bacterial and viral systems where multiple innate cytokines can
promote CTL effector differentiation [28,29], in T. gondii infection,
IL-12 appears to singularly control CD8+ T cell differentiation
and IFN-c production [22,30,31]. Given the absolute requirement
for IFN-c in CTL protective immunity to T. gondii, it is difficult to
assess whether memory responses will be enhanced under
conditions of complete and permanent IL-12 deficiency. There-
fore, to determine to what extent IL-12 negatively impacts
memory response to the parasite, we examined the effects of IL-
12 insufficiency during primary CTL activation on subsequent
effector and memory responses recalled in the presence of IL-12.
Interestingly, the requirement of IL-12 for IFN-c production
during the primary response was imprinted only on effector
memory cells during an immediate recall response. However,
central memory tgd057-specific CTLs, primed in the absence of
IL-12 but recalled in an IL-12 competent environment, were able
to repopulate the secondary immune response with IFN-c
producing effector memory cells. Our results indicate that IL-12
has divergent consequences for heterogeneous CD8+ subpopula-
tions. Whereas IL-12 is required for effector memory differenti-
ation of KLRG1+ subsets, it is not required for central memory
differentiation, and may even negatively impact TCM function.
Results
Identification of a novel H-2K
b-restricted CD8+ T cell
population specific for the Toxoplasma antigen tgd057
Given that the T. gondii secreted proteins GRA1, GRA7, ROP1,
ROP2, and the parasite surface protein SAG1 have previously
been shown to elicit CTL responses in C57BL/6 mice, we initially
screened these proteins for putative CTL epitopes. Their predicted
protein sequences were analyzed for peptide epitopes using a
program that combines four different prediction routines to choose
the octameric or nonameric peptide sequences with the highest
potential for binding either H-2K
b or H-2D
b molecules,
respectively [32]. These putative peptide epitopes (Table S1) were
synthesized and individually loaded onto the corresponding MHC
class I tetramers [33,34] using caged MHC class I tetramer
technology [18,35]. Peptide-MHC tetramers were screened for
binding to purified CD8+ T cells harvested from spleens of CPS-
vaccinated mice. Purified naı ¨ve CD8a+ splenocytes were used as a
negative control. From this first screen, we were unable to confirm
the presence of a genuine CTL epitope (data not shown).
Therefore, we screened for peptide epitopes from a second, more
extensive set of Toxoplasma proteins using the same method (Tables
S2 and S3). Included in the second screen was a large set of
secreted proteins (both confirmed and uncharacterized but likely
secreted based on sequence) as well as a few non-secreted proteins
[17]. This second screen resulted in the discovery of a single
genuine CTL epitope – SVLAFRRL – derived from the gene
tgd057 (Figure 1A), which encodes a putatively secreted protein of
unknown function [36].
From its initial characterization, Wan et al reported that the
tgd057 gene sequence encoded a secretion signal peptide (residues
1–21), which would allow for trafficking to the three secretory
organelles: micronemes, rhoptries, or dense granules. Since tgd057
contains no other known targeting motif, we predicted that tgd057
would reside in the dense granules, the default pathway for the
constitutive secretion of proteins into the parasitophorous vacuole
[37]. To establish the localization of tgd057, we first generated
polyclonal antisera against recombinant tgd057. Anti-tgd057
antibodies were further purified from the antisera by reactivity
to recombinant protein bound to nitrocellulose and extraction
from tgd057+ bands. To demonstrate the specificity of our
purified, polyclonal anti-tgd057 Abs, we compared their reactivity
to recombinant tgd057 protein, uninfected HFF lysates, and CPS-
infected HFF lysates. To further characterize tgd057, we
performed the protein extraction using two different buffers:
modified RIPA and 1% Triton X-100. The anti-tgd057 Abs
showed no reaction to either the supernatant or pellet of mRIPA-
extracted, uninfected HFF lysates (Figure 1B, lanes 2 and 3).
However, there is a clear band in the pellet but not supernatant of
the mRIPA-extracted CPS-infected HFF lysate (Figure 1B, lanes 4
and 5), corresponding to a band in the recombinant tgd057 lane
Author Summary
Toxoplasma gondii is a ubiquitous protozoan parasite that
causes severe disease in people with compromised
immune function. It is known that CD8+ T cells are
essential for the establishment of protective immunity,
primarily through the delivery of the effector cytokine
interferon-c (IFN-c)t oToxoplasma-infected cells. However,
it remains unclear how memory CD8+ T cells develop in
response to Toxoplasma infection, and to what extent
inflammatory cytokines like interleukin-12 (IL-12) play a
role in memory development. Furthermore, the natural T.
gondii antigens that induce CD8+ T cell activation have not
yet been fully uncovered. Using new technology for the
screening of antigen specificity, we discovered the first
natural antigen-specific CD8+ T cell population induced by
T. gondii infection in C57BL/6 mice. By tracking natural
parasite-specific responses, we found that IL-12 plays a
vital role in promoting the development of IFN-c-
producing effector memory CD8+ T cells but at a cost to
the numbers and function of central memory CD8+ T cells.
IL-12 and T. gondii CD8 Memory
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infected HFF lysate, the majority of tgd057 partitioned to the
insoluble fraction. (Figure 1B, lanes 6 and 7). Moreover, multiple
minor tgd057 bands with slower mobility were also visible in the
mRIPA- and Triton X-100-insoluble CPS-infected HFF lysates,
suggesting presence of tgd057 isoforms. Overall, the insolubility of
tgd057 in mRIPA and Triton X-100 buffers suggests that tgd057 is
associated with membrane insoluble structures such as the
parasite’s cytoskeleton, although some may be trafficked to
membrane soluble structures such as the secretory organelles.
To further characterize the localization of tgd057, immunoflu-
orescence staining was performed on HFFs infected with GFP-
expressing RH parasites. As depicted in Figure 1C, the staining
pattern is unlike that of the secretory organelles and appears to
stain structural elements near the apical complex and also at the
posterior end of the parasite. To confirm that tgd057 is resistant to
detergent extraction as suggested by Figure 1B, infected HFFs
were treated with 1% Triton X-100 to remove membrane-
associated proteins prior to staining. In Triton X-100-treated
samples, tgd057 staining is clearly retained (Figure 1D).
Tgd057-specific CD8+ T cells are effector cells
phenotypically representative of the polyclonal CTL
population
Although the precise localization and function of tgd057
remains to be elucidated, it is clear from our screen that tgd057
is available for processing and presentation to CD8+ T cells in
vivo. To ascertain the relationship between epitope-specific CD8+
T cells and the polyclonal response to T. gondii infection, the
numbers and activation phenotype of tgd057-specific cells were
compared to that of the total CD8+ T cell population after
vaccination or infection with avirulent parasites. Mice were
vaccinated with a single dose of attenuated, CPS-mutant parasites
Figure 1. Tgd057 localizes to the parasite’s cytoskeleton. A) Example output data from the screening of putative CTL epitopes derived from
GRA4, upper panels, and tgd057, lower panels. The GRA4-epitope tetramer was scored as negative for binding to day 7 CPS-primed CD8a+ T cells,
whereas the tgd057-epitope tetramer (K
b/SVLAFRRL) was scored as positive. B) Western blot of CPS parasite cultures using purified anti-tgd057 Abs.
Lane 1, 0.15 mg of recombinant tgd057. Lanes 2–3, supernatant and pellet, respectively, of an uninfected HFF culture extracted in mRIPA buffer. Lanes
4–5, supernatant and pellet, respectively, of a CPS-infected HFF culture extracted in mRIPA buffer. Lanes 6–7, supernatant and pellet, respectively, of a
CPS-infected HFF culture extracted in 1% Triton X-100 buffer. C and D) Immunofluorescence images of HFFs infected with GFP-RH parasites for
4 hours. C, Cells were fixed and stained with anti-tgd057 Abs, and the nuclear stain DAPI. D, Cells were fixed, treated with 1% Triton X-100 for 20 min,
and then stained as in C.
doi:10.1371/journal.ppat.1000815.g001
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primed CD44
hi tgd057-specific CTLs, which constituted 7.66% of
the total PEC CD8+ T cells and 2.92% of the total splenic CD8+
T cells on day 8 post-vaccination (Figure 2A and 2B). As we have
previously published [22], the polyclonal CTL response is
composed of four subpopulations based on the expression of the
cell surface activation markers–CD62L and KLRG1. The four
subpopulations are termed Fraction (F) I (CD62L
hi KLRG1-), FII
(CD62L
lo KLRG1-), FIII (CD62L
lo KLRG1+), and FIV
(CD62L
hi KLRG1+). FI was thought to contain undifferentiated
CD8+ T cells due to the lack of granzyme B and IFN-c expression
during the primary effector response. Furthermore, the FI
phenotype is shared by the majority of CD8+ T cells in the
spleens of naı ¨ve mice (Figure 2A). The other three subpopulations
induced by Toxoplasma infection contained varying levels of
granzyme B+ and IFN-c+ effector cells, with FIII representing
the most effector cell-rich subpopulation [22]. When the PEC
tgd057-specific cells were analyzed for CD62L and KLRG1
expression after CPS vaccination, all four subpopulations were
represented, including the seemingly undifferentiated FI subset
(Figure 2B). In the spleens of these mice, all four subpopulations of
tgd057-specific CTLs were also present, although mature FIII
phenotype cells were over-represented. To view the immune
response to natural Toxoplasma infection, mice were perorally
infected with cysts of the avirulent ME49 strain, which not only
acutely infects the host, but also establishes chronic infection in the
brain and muscle tissue. During the acute phase of ME49
infection, CD44
hi tgd057-specific CD8+ T cells were present both
in the PECs and in the spleen at a comparable frequency to CPS
vaccination (Figure 2C), however ME49 infection induced fewer
numbers of tgd057-specific CTLs in these tissues (Figure S1).
Heterogeneous effector CTL subpopulations were similarly
induced by ME49 infection, but the tgd057-specific CTLs were
particularly enriched in FIII phenotype cells, both in the PECs and
the spleen. During the chronic phase of ME49 infection, the
frequencies and numbers of PEC and splenic CD44
hi tgd057-
specific CTLs were reduced but still detectable (Figure 2D and S1).
In all three tissues sampled, the tgd057-specific CTLs were
representative of the total CD8+ T cell population. Interestingly,
FIII CTLs remained a major subpopulation both in the spleen and
in the periphery, suggesting that KLRG1 positivity can indeed be
a stable, long-lasting phenotype. A significant pool of tgd057-
specific CTLs was found in the brains of chronically infected mice,
a site of spontaneous T. gondii recrudescence, where FII and FIII
were the predominant subpopulations (Figure 2D and S1). In
general, tgd057-specific CTLs were phenotypically similar to the
polyclonal CD8+ T cell population, except during acute infection,
where mature effector-phenotype cells were enriched and the
naı ¨ve-like subpopulation was diminished in the spleen.
Analysis of effector molecule expression between the epitope-
specific and total CD8+ T cell populations would provide a direct
assessment their relative effector capability. Therefore, granzyme
B and IFN-c production were measured in both tgd057-specific
CTLs and the total CD8+ T cell population. Effector cells from
day 8 CPS-primed mice were compared to naı ¨ve splenocytes and
evaluated for granzyme B and IFN-c co-expression ex vivo and in
Figure 2. Tgd057-specific CTLs are induced by CPS vaccination and natural ME49 infection. Samples from A) naı ¨ve mice and B–D) T.
gondii infected mice were stained for CD44 and K
b/SVLAFRRL positivity and the expression of CD62L and KLRG1 in CD8+ T cells ex vivo. Upper row,
frequency of CD44
hi K
b/SVLAFRRL+ cells of total CD8a+ TCRb+ cells. Middle row, total CD8a+ cells were analyzed for CD62L and KLRG1 expression.
Lower row,K
b/SVLAFRRL+ CD8a+ cells were analyzed for CD62L and KLRG1 expression. A) Spleens were harvested from naı ¨ve mice. B) Mice were
vaccinated with CPS parasites and PECs and spleens were harvested on day 8 post-vaccination. C) PECs and spleens were harvested on day 7 post-
infection of mice perorally infected with 20 ME49 cysts. D) PECs, spleens, and the brain mononuclear cells were analyzed in day 48 cyst-infected mice
(as in C). One representative mouse was shown of at least three samples. For the PEC and spleen analysis in A–D, one of at least three independent
experiments is shown. For the brain mononuclear cell analysis in D, one of two experiments is shown.
doi:10.1371/journal.ppat.1000815.g002
IL-12 and T. gondii CD8 Memory
PLoS Pathogens | www.plospathogens.org 4 March 2010 | Volume 6 | Issue 3 | e1000815response to live parasite infection or peptide restimulation
(Figure 3). Tgd057-specific CTLs were highly enriched in
granzyme B+ effector cells ex vivo; 54% and 49% of the PEC
and splenic tgd057-specific CTLs were granzyme B+, respectively,
whereas in the total PEC and splenic CD8+ T cells, 29% and 8%
were granzyme B+, respectively (Figure 3A). After restimulation
with CPS parasites both IFN-c and granzyme B were upregulated
in total PEC and splenic CD8+ T cells, of which the tgd057-
specific CTLs remained enriched in frequency of effector
molecule-positive cells (Figure 3B). Whole PECs and spleen
cultures were also subjected to peptide restimulation to demon-
strate the specificity of tgd057-specific CTLs. As shown in
Figure 3C, IFN-c was induced by both PEC and splenic CD8+
T cells in the presence of cognate peptide (SVLAFRRL) but not
non-cognate peptide (SIINFEKL). The frequency of tgd057-
specific cells and thus K
b/SVLAFRRL+ IFN-c+ cells was reduced
after cognate peptide restimulation, a response we attributed to
TCR downregulation, a well-characterized response to strong
TCR ligation [40]. Taken together, tgd057-specific CTLs are
highly enriched in granzyme B+ effector cells and produce the
protective cytokine IFN-c in response to live parasites and cognate
peptide.
Figure 3. Effector molecule expression among tgd057-specific CTLs. Expression of IFN-c and granzyme B was analyzed in CD8+ T cells from
naı ¨ve and day 8 CPS-primed mice. A) The frequencies of tgd057-specific CTLs (CD44
hi,K
b/SVLAFRRL+, CD8a+, and TCRb+ cells) was compared
between naı ¨ve and primed samples ex vivo, upper row. IFN-c and granzyme B expression was evaluated between CD8+ T cells from the naı ¨ve spleen,
and total CD8+ T cells and tgd057-specific (Tetramer+) CD8+ T cells from day 8 CPS-primed PECs and splenocytes, lower row. For each of these
populations, IFN-c and granzyme B expression was analyzed after CPS restimulation (B) and peptide restimulation (C). B) Samples were either
unstimulated (upper row) or restimulated (lower row) with CPS parasites. C) Samples were directly incubated with either non-cognate (SIINFEKL, upper
row) or cognate (SVLAFRRL, lower row) peptide. FACS plots represent one of three mice. One of three independent experiments is shown.
doi:10.1371/journal.ppat.1000815.g003
IL-12 and T. gondii CD8 Memory
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specific CTLs
We have previously demonstrated that the innate cytokine IL-
12 produced during Toxoplasma vaccination induces CTL IFN-c
production and suggested that IL-12 promotes terminal matura-
tion at the expense of memory precursor subpopulation differen-
tiation [22]. A limitation of our earlier study was that putative
parasite-reactive CD8+ T cells were phenotypically defined by
activation markers (CD62L downregulation and KLRG1 upregu-
lation) and effector molecule expression (granzyme B and IFN-c),
rather than by parasite-antigen specificity. By definition, we were
not able to detect parasite-antigen specific CTLs or CTL
precursors that have yet to express activation markers or effector
molecules. Utilizing tetramer staining we are now able to resolve
the totality of the natural tgd057-specific CTL response, which
includes a significant proportion of undifferentiated FI-phenotype
cells (Figure 2B–2D). This allows us to address the question of
whether IL-12 truly negatively impacts the KLRG1- putative
memory precursor compartment, which encompasses TCM-like FI
(CD62L
hi KLRG1-) and TEM-like FII (CD62L
lo KLRG1-)
precursor cells. To firmly address the requirements of IL-12
during the primary activation of parasite-specific CTLs, tgd057-
specific cells were enumerated and phenotyped in WT and
Il12a(IL-12p35)
2/2 CPS-primed mice. On day 7 post-vaccination,
the numbers of total and tgd057-specific CTLs were 3-fold lower
in PECs of Il12a
2/2 mice (Figure 4A). In the spleen, the total
numbers of CD8+ T cells were unchanged in Il12a
2/2 mice,
although the numbers of tgd057-specific CTLs were slightly lower
Figure 4. Primary CTL activation and differentiation in Il12a
2/2 mice. PECs and spleens were analyzed for CTL activation on day 7 post-
vaccination in WT and Il12a
2/2 mice. A and B) Total CD8a+ TCRb+ cells and CD44
hi K
b/SVLAFRRL+ CD8+ T cells were enumerated in PECs (A) and
splenocytes (B) of WT naı ¨ve, WT primed, and Il12a
2/2 primed mice. C and D) Subpopulation distribution is shown in total CD8a+ cells and K
b/
SVLAFRRL+ CD8a+ cells in PECs (C) and splenocytes (D) of WT and Il12a
2/2 primed mice. PEC samples were pools of three mice. Bar graphs are shown
as mean 6 SEM of three mice. Pie charts are shown as mean values for the spleen samples. Data are representative of three independent
experiments.
doi:10.1371/journal.ppat.1000815.g004
IL-12 and T. gondii CD8 Memory
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results, the distribution of total PEC effector CD8+ subpopulations
shifts in IL-12-deficient mice such that the KLRG1- fractions FI
and FII increase in frequency, while the KLRG1+ fractions FIII
and FIV become severely diminished in frequency (Figure 4C, left
column). Notably, the vast majority of Il12a
2/2 tgd057-specific
CTLs were FI and FII (Figure 4C, right column), mirroring the shift
among total PEC CTL populations in the absence of IL-12. This
effect was also observed in splenic tgd057-specific CD8+ T cells
(Figure 4D). Therefore among both total and tgd057-specific
CTLs, pro-inflammatory IL-12 signaling clearly induces the
differentiation of the KLRG1+ effector subpopulations FIII and
FIV at the expense of the KLRG1- memory precursor subsets FI
and FII.
As predicted by our previously published results, IFN-c-
producing effector CD8+ T cells fail to differentiate in Il12a
2/2
PECs and splenocytes, when assayed by ex vivo restimulation with
live parasites (Figure 5A and 5B, left panels). When gated on
tetramer+ CTLs, it is also clear that Ag-specific CTLs primed in
the absence of IL-12 do not produce IFN-c in response to parasite
restimulation (Figure 5A and 5B, right panels). Although the
functional defect in CD8+ T cell IFN-c production due to in vivo
IL-12 deficiency is striking, it is still not clear whether this defect is
a result of aberrant in vivo differentiation or the lack of IL-12
signaling during ex vivo restimulation. Therefore, day 8 CPS-
primed WT and Il12b(IL-12p40)
2/2 cells were restimulated under
different culture conditions to elucidate the individual contribu-
tions of parasite antigens and IL-12 signaling for CD8+ T cell
IFN-c production ex vivo (Figure S2). Neutralizing IL-12 signaling
during restimulation with anti-IL-12p40 Abs reduced IFN-c
production in WT CTLs but had no affect on Il12b
2/2 CTLs
(green vs. yellow bars). The addition of rIL-12p70 alone stimulated
a low percentage of WT CTLs to produce IFN-c, however,
Il12b
2/2 CTLs were insensitive to exogenous IL-12 signaling (blue
vs. purple bars). The addition of CPS parasites plus rIL-12p70 into
the restimulation culture not only induced WT CTLs to make
more IFN-c, but also allowed for Il12b
2/2 CTLs to produce
IFN-c (red bars). However, the frequency of IFN-c+ cells among
Figure 5. Tgd057-specific CTLs primed in Il12a
2/2 mice do not produce IFN-c in response to parasite restimulation. Day 7 CPS-primed
PECs and spleens were restimulated ex vivo to assay IFN-c production. A and B) PECs (A) and splenocytes (B) were restimulated with CPS parasites ex
vivo. The frequency of IFN-c+ cells was determined among total CD8a+ CD3e+ cells of WT naı ¨ve, WT primed, and Il12a
2/2 primed PECs and spleens,
left panels. The frequency of IFN-c+ cells was determined among total K
b/SVLAFRRL+ CD8a+ CD3e+ cells of WT naı ¨ve, WT primed, and Il12a
2/2
primed PECs and spleens, right panels. C and D) PECs (C) and splenocytes (D) were directly restimulated with a range of cognate and non-cognate
peptide concentrations ex vivo. The frequency of IFN-c+ cells was determined among total K
b/SVLAFRRL+ CD8a+ CD3e+ cells of WT primed, and
Il12a
2/2 primed cells. All values are mean 6 SEM of three mice. Data are representative of three independent experiments.
doi:10.1371/journal.ppat.1000815.g005
IL-12 and T. gondii CD8 Memory
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2/2 CTLs was much lower relative to the WT CTLs in
both the PECs and the spleen. Therefore, exogenous IL-12
signaling can synergize with antigenic stimulation to induce IFN-c
production in Il12b
2/2 CTLs, however, it cannot fully recover to
WT levels, due to the prominent defect in differentiation that
occurs with IL-12 deficiency.
Because parasite restimulation induces both Ag-dependent T
cell activation and cytokine-induced bystander activation, WT and
Il12a
2/2 cells were restimulated with varying concentrations of
cognate peptide to determine the ability of tgd057-specific CTLs
to respond to TCR ligation only. Surprisingly, both WT and
Il12a
2/2 tgd057-specific CTLs mounted IFN-c responses to
increasing concentrations of cognate peptides (Figure 5C and
5D). The normal IFN-c responses of Il12a
2/2 CTLs during
peptide restimulation indicate that strong TCR signaling can also
overcome the functional defect observed during CPS restimula-
tion. In cultures stimulated with live parasites, it may be that only
very low concentrations of SVLAFRRL-peptide are available on
antigen presenting cells, thus explaining the strict requirement for
pro-inflammatory IL-12 signaling. The difference between micro-
bial and peptide restimulation is an important one and we believe
that the IFN-c responses to whole parasite restimulation better
reflects the physiological effector function of CTLs in vivo, as it is
well documented that IL-12-deficient mice rapidly succumb to
toxoplasmosis due to the lack of T cell IFN-c production [20,31].
Effector memory CTL differentiation in IL-12-deficient
immune mice
In the murine model of listeriosis, Pearce et al demonstrated
that IL-12 deficiency enhances bacterial immunity through the
increased generation of memory precursor CTLs (specific for the
model antigen OVA) [27]. However, it is not known whether IL-
12 has a similar role in memory CTL responses to parasites. Given
the differential requirements of IL-12 for effector CTL subset
differentiation in the primary response (Figure 4C and 4D), it may
be that the enhancement of CD8 memory in IL-12-deficient
conditions will be evident as an increase in the frequency of one or
more subpopulation(s). By tracking the development and effector
function of tgd057-specific CTLs in WT and IL-12-deficient
immune mice, we can for the first time elucidate the role of IL-12
in effector/memory differentiation of a natural CTL population
induced by parasite vaccination. In agreement with studies in
bacterial and viral systems [27,41], the numbers of PEC tgd057-
specific CTLs were greater in Il12a
2/2 immune-rested mice (day
30 post-vaccination) compared to WT immune-rested mice,
despite similar numbers of total CD8+ T cells (Figure 6A). In
the spleens of Il12a
2/2 immune mice, however, the numbers of
total CD8+ T cells and tgd057-specific CTLs were reduced on
average, but not significantly different (Figure 6B). Tgd057-specific
CD8+ T cells of WT immune-rested mice remained heteroge-
neous, with FI, FII, and FIII subsets present in PECs and the
spleen (Figure 6C and 6D, upper row). The KLRG1+ FIII subset
represented a major subpopulation of tgd057-specific memory
CTLs. This is surprising since KLRG1 positivity is a marker of
replicative senescence [24]. Despite the apparent longevity of some
KLRG1+ cells, the effect of IL-12 deficiency persisted in memory
tgd057-specific CTLs, where the balance of KLRG1 negative and
positive subpopulations continued to favor the KLRG1- subsets in
the absence of IL-12 (Figure 6C and 6D). Strikingly, the FI
subpopulation remained a major constituent of the PEC tgd057-
specific CTLs of Il12a
2/2 immune mice, whereas this subset was
virtually absent from the PEC tgd057-specific CTLs of WT
immune mice (Figure 6C), an effect that was not reflected in the
total WT and Il12a
2/2 PEC populations. Hence, IL-12 deficiency
during the priming of tgd057-specific CTLs may indeed result in a
greater proportion of KLRG1- memory CTLs.
The persistent changes in subpopulation distributions observed
in Il12a
2/2 immune rested mice suggested that there may also be
long-lasting functional defects in TEM IFN-c responses. After ex
vivo parasite restimulation, Il12a
2/2 memory CTLs mounted a
weak recall response, whereas WT memory CTLs were efficient
IFN-c producers, especially in peripheral tissue (Figure 6E and 6F,
left panels). As previously observed in the primary response,
tetramer+ CD8+ T cells from Il12a
2/2 immune mice were
competent IFN-c producers after cognate peptide restimulation
(Figure 6E and 6F, right panels). Therefore the enrichment of
KLRG1- memory CTL precursors in IL-12 deficient conditions
may be carried over from the primary response into the memory
phase, where the KLRG1- subpopulations FI and FII account for
nearly 75% of all tgd057-specific memory CTLs compared to 46%
in WT immune mice. However, IL-12 remains a critical signal for
IFN-c production to parasite restimulation in primary-effector and
effector-memory CD8+ T cells.
IL-12 signaling during primary CTL activation is required
for immediate recall responses but not for secondary CTL
activation in immune mice
Although IL-12 is required for primary-effector and effector-
memory differentiation, it is not yet clear how it may affect central
memory CD8+ T cells. In primary anti-Toxoplasma effector CTLs,
we have previously shown that the FII, FIII, and FIV
subpopulations were equally responsive to ex vivo IL-12 signaling
via pSTAT4 activation [22]. However, the FI subset was
unresponsive to IL-12 signaling, suggesting that the detrimental
effects of IL-12 in short-lived effector cell differentiation might
spare the FI subset during the primary response. Since these TCM-
phenotype FI cells are enriched in Il12a
2/2 immune mice, TCM
function might be normal or even enhanced in memory CTLs
differentiated in an IL-12 deficient environment. To test this
hypothesis, we transiently neutralized IL-12 in vivo during
primary vaccination and queried the ability of the subsequent
IL-12-sufficient immune mice to mount an immediate recall
response in vivo and to generate effector memory cells 6 days after
secondary challenge. Similar to the effects of genetic deletion of
IL-12, mice that received anti-IL-12p40 Abs generated reduced
numbers of PEC tgd057-specific CTLs on day 8 post-vaccination,
which were diminished in KLRG1+ subsets and refractory to CPS
restimulation (Figure 7A–7C). The effect of IL-12 neutralization
was less severe in the spleen, which may be due to the i.p. route of
Ab administration. On day 28 after the initial vaccination, the
numbers of tgd057-specific CTLs were increased in PECs but
decreased in the spleen of anti-IL-12 treated mice (Figure 7D),
similar to Il12a
2/2 immune rested mice. Furthermore, KLRG1+
subsets, especially FIII, were under-represented in PEC and
splenic tgd057-specific CTLs compared to control mice
(Figure 7E). To test if effector memory CTLs from IL-12-
neutralized immune mice could mount an immediate recall
response in IL-12 replete conditions, mice were rechallenged with
CPS parasites in vivo. PECs were harvested 12 hours later and
directly stained for effector molecule expression. As shown in
Figure 7F, recalled control effector memory CTLs expressed
granzyme B and IFN-c whereas those from IL-12 neutralized mice
did not. Therefore, the effect of IL-12 deficiency during priming is
imprinted on TEM and cannot be ameliorated by the IL-12
sufficient conditions prevailing during the immediate recall
response. As a measure of TCM function, which is distinguished
by high proliferative potential, IL-12-neutralized immune mice
were rechallenged with a high dose of CPS parasites and assayed
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vaccination) WT and Il12a
2/2 mice were analyzed for numbers, phenotype, and effector function in memory CTLs. A and B) Total CD8a+ TCRb+ cells
and CD44
hi K
b/SVLAFRRL+ CD8+ T cells were enumerated in PECs (A) and spleens (B) of WT and Il12a
2/2 immune mice. C and D) Subpopulation
distributions were shown in total CD8a+ cells and K
b/SVLAFRRL+ CD8a+ cells in PECs (C) and spleens (D) of WT and Il12a
2/2 immune mice. E and F,
left panels) WT and Il12a
2/2 immune CD8a+ T cells among PECs (E) and from the spleen (F) were analyzed for IFN-c positivity after restimulation with
CPS parasites in vitro. E and F, right panels) WT and Il12a
2/2 immune K
b/SVLAFRRL+ CD8a+ cells among PECs (E) and from the spleen (F) were
analyzed for IFN-c positivity after restimulation with either non-cognate (SIINFEKL) or cognate peptides (SVLAFRRL) in vitro. PEC samples were pools
of four mice. Bar graphs are shown as mean 6 SEM of four mice. Pie charts are shown as mean values for the spleen samples. One of two
representative experiments is shown.
doi:10.1371/journal.ppat.1000815.g006
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challenge, the numbers of tgd057-specific CTLs, effector subset
distribution, and effector function normalized between control and
IL-12-neutralized groups (Figure 7G–7I). Taken together, these
data suggest that central memory CD8+ T cells develop normally
in the absence of IL-12 during the initial priming events.
IL-12 negatively regulates memory marker-expression
among tgd057-specific CTLs
It has become clear that IL-12 deficiency results in the loss of
KLRG1+ effector CTLs and hinders the ability of primary and
memory cells to respond to parasite rechallenge. While CD8+ T
cell numbers and function rely on IL-12, it is not yet clear if there
is a qualitative change among memory precursor cells differen-
tiated in the absence of IL-12 during T. gondii infection.
Therefore, we probed for qualitative changes in memory
phenotype between WT and Il12b
2/2 CD8+ T cells during
primary (day 8) and memory (day 40) phases. CD127 (IL-7Ra)i s
a memory marker known to be selectively expressed on memory
precursor cells [42], which is necessary for their survival [43]. As
shown in Figure 8A, there was a greater frequency of splenic
tgd057-specific memory precursor cells expressing CD127 from
Figure 7. In vivo IL-12 neutralization during vaccination generates defective effector memory but not central memory CTLs. All mice
were treated with Abs against IL-12p40 or an isotype control during CPS vaccination. A–C) To confirm the effect of IL-12 neutralization, PECs and
spleens were analyzed for the activation of tgd057-specific CTLs on day 8 post-vaccination in IL-12p40 treated (Rx) or isotype Rx mice. CD44
hi K
b/
SVLAFRRL+ CD8a+ TCRb+ cells were enumerated in A, and the subpopulation distributions of K
b/SVLAFRRL+ CD8a+ cells were given in B. Samples
were restimulated with CPS parasites and the frequency of IFN-c+ cells in total K
b/SVLAFRRL+ CD8a+ cells is shown in C. D and E) Resting numbers
and subpopulation distributions of tgd057-specific CTLs were analyzed in IL-12p40 Rx or isotype Rx immune rested mice as in A and B. F) Immune
rested mice were in vivo rechallenged with 2610
6 CPS parasites for 12 hrs. PECs from IL-12p40 Rx or isotype Rx rechallenged immune mice were
harvested and ex vivo stained for IFN-c and granzyme B expression in total CD8a+ TCRb+ cells. FACS plots are from one of three mice per group. G–I)
Immune rested mice were in vivo rechallenged with 10
7 CPS parasites. On day 6 post-rechallenge, PECs and spleens were analyzed for the secondary
activation of tgd057-specific CTLs. G and H) Resting numbers and subpopulation distributions of tgd057-specific CTLs were analyzed in IL-12p40 Rx or
isotype Rx immune rested mice as in A and B. I) IFN-c production was assessed in K
b/SVLAFRRL+ CD8a+ cells after CPS restimulation. PEC samples
were pools of 3–4 mice. For unpooled samples, bar graphs are shown as mean 6 SEM of 3–4 mice and pie charts are mean values of 3–4 mice. One of
two representative experiments is shown.
doi:10.1371/journal.ppat.1000815.g007
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enhanced CD127 positivity persisted among splenic memory
tgd057-specific CTLs on day 40 post-vaccination. As a second
measure of memory quality, IL-2 expression, a characteristic of
memory-lineage CD8+ T cells [42], was also analyzed. IL-2
positivity has been used in conjunction with TNFa and IFN-c
positivity to define ‘‘multifunctional’’ TH1 cells that are protective
against Leishmania major [44], and similarly with CD8+ T cells, the
presence of multifunctional CTLs correlates with vaccine efficacy
[45]. To measure IL-2 expression via intracellular staining we
restimulated splenocytes with the polyclonal T cell activators
PMA and ionomycin, and therefore, memory-lineage cells will be
both IFN-c+ and IL-2+.L i k eC D 1 2 7 ,t h ef r e q u e n c yo fI F N - c+
IL-2+ cells among splenic tgd057-specific CTLs was significantly
increased in IL-12-deficient mice on day 8 (Figure 8B). However,
there was no significant difference IFN-c/IL-2-positivity between
WT and Il12b
2/2 memory tgd057-specific CTLs, which is
probably due to the ability of all memory CD8+ T cells to
produce IL-2. Therefore, there is a qualitative shift among
primary tgd057-specific CTLs whereby this population appears
more memory-like in the absence of IL-12. Furthermore, the
enhanced CD127 positivity among IL-12-deficient CTLs is
retained from the primary phase to the memory phase, showing
that the effects of IL-12 deficiency can fixed as memory CTLs
progressively differentiate over time.
Central memory CTLs differentiated in the absence of IL-
12 are superior generators of secondary effector cells
Transient IL-12-neutralization during T. gondii infection sug-
gested that TCM development does not require IL-12. However,
due to the limitations of our experimental approach, it is not yet
certain whether the complete absence of IL-12 will alter the
functional quality of TCM. To more precisely assay the functional
capabilities of central memory CTLs differentiated under IL-12-
deficient conditions, CD44
hi FI CD8+ splenocytes from WT and
Il12a
2/2 immune mice were sorted and co-transferred into naı ¨ve
recipient mice. Given the increased precursor frequency of FI+
tgd057-specific memory CTLs in Il12a
2/2 immune mice
(Figure 5C), donor FI+ CTLs were normalized such that the
same number of predicted tgd057-specific cells of each genotype
were transferred. Recipient, WT immune donor, and Il12a
2/2
immune donor CTLs were distinguished based on the expression
of differential congenic markers (Figure 9A). Chimeric mice were
then challenged with CPS parasites and assayed for CTL
activation and differentiation 5.5 days later. Despite having
transferred the same number of tgd057-specific F1 cells (but
58% fewer total FI CD8+ T cells) from immune Il12a
2/2 mice,
secondary tgd057-specific CTLs derived from Il12a
2/2 TCM were
nearly 10-fold more frequent than those derived from WT TCM
among PECs on day 5.5 post-challenge (Figure 9A and 9B).
Although PEC tgd057-specific CTLs of donor-origin did not
Figure 8. IL-12 inhibits CD127 and IFN-c/IL-2 expression among tgd057-specific CTLs. WT and Il12b
2/2 mice were vaccinated with CPS
parasites and spleens were harvested on day 8 (D8) and day 40 (D40, Immune) post-vaccination and analyzed by flow cytometry for memory markers
expression among tgd057-specific CTLs. A) Ex vivo analysis of CD127 expression. Left panel, histograms of CD127 expression among either total
CD8a+ TCRb+ cells (total CD8+ T cells) or CD44
hi K
b/SVLAFRRL+ CD8a+ TCRb+ cells (Tetramer+ CD8+ T cells) from each group. Right panel, mean
values of the frequency of CD127+ cells gated on Tetramer+ CD8+ T cells. B) IFN-c and IL-2 expression after ex vivo restimulation with PMA and
ionomycin for 4 hours. Left panel, IFN-c and IL-2 co-expression profiles among either total CD8+ T cells or Tetramer+ CD8+ T cells from each group.
Right panel, mean values of the frequency of IFN-c and IL-2 double-positivity gated on Tetramer+ CD8+ T cells. Bar graphs are shown as mean 6 SEM
of four mice. n.s., not significant.
doi:10.1371/journal.ppat.1000815.g008
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response, secondary tgd057-specific CTLs derived from Il12a
2/2
TCM were present in significantly greater cell numbers compared
to those derived from WT TCM (Figure 9C). Ex vivo phenotypic
analysis of donor CTL populations revealed that FI TCM
generated phenotypically heterogeneous secondary effector CTLs
regardless of their origin (Figure 9D). Upon restimulation of
PECs from chimeric mice, granzyme B+ and IFN-c-producing
effector memory cells were evident in CTL populations originating
from both WT and Il12a
2/2 TCM donor cells (Figure 9E).
Consistent with our data shown in Figure 7, it is clear that the
development of central memory FI CTLs does not require IL-12.
Remarkably, the resultant central memory CTLs differentiated
under IL-12-deficient conditions and recalled in an IL-12 sufficient
environment have a qualitative advantage in generating a
functionally diverse population of secondary effector CTLs.
Taken together with the increased representation of F1 memory
CTLs observed after priming in the absence of IL-12 (Figure 6),
Figure 9. Central memory CTLs from Il12a
2/2 mice are functionally competent. CD44
hi FI central memory CD8a+ cells from the spleens of
WT and Il12a
2/2 immune mice were FACS-sorted and then co-transferred into WT naı ¨ve mice. We calculated to have transferred ,1800 FI tgd057-
specific memory precursors of each genotype into each recipient mouse. One day post-transfer, chimeric mice were challenged with 3610
6 CPS. On
day 5.5 post-challenge, PECs were analyzed for the generation tgd057-specific CTLs, subpopulation distributions, and effector function. A, left panel)
Donor and recipient cells were distinguished based on the expression of congenic markers. Recipient mice were CD45.2+ and CD90.2-, cells of WT FI
TCM origin were CD45.2- and CD90.2+, and cells of Il12a
2/2 FI TCM origin were CD45.2+ and CD90.2+. The FACS plot shows the relative frequencies of
recipient and donor-derived CD8a+ TCRb+ cells among PECs on day 5.5 post-challenge. A, right panel) The frequency of CD44
hi K
b/SVLAFRRL+ CD8a+
T cells among total CD8+ T cells is shown for each gated population in the left panel. B and C) The frequency (B) and absolute cell numbers (C)o f
CD44
hi K
b/SVLAFRRL+ CD8a+ T cells among recipient and donor groups. Bar graphs represent mean values 6 SEM of 4 chimeric mice. D)
Subpopulation distributions of total CD8+ T cells (upper row) and K
b/SVLAFRRL+ CD8a+ T cells (lower row) among recipient and donor groups. E)
Granzyme B and IFN-c expression in total CD8+ T cells (upper row) and K
b/SVLAFRRL+ CD8a+ cells (lower row) among recipient and donor groups
after in vitro CPS restimulation. All FACS plots are from one representative chimeric mouse. One of two independent experiments is shown.
doi:10.1371/journal.ppat.1000815.g009
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formed in IL-12 deficient hosts indicates that IL-12 negatively
impacts the central memory compartment both quantitatively
and qualitatively.
Discussion
Using caged MHC class I tetramer screening, we have
discovered a new H-2K
b-restricted CTL epitope SVLAFRRL,
derived from the T. gondii protein tgd057. Tgd057 joins a growing
list of newly identified CTL-targeted Toxoplasma antigens,
including GRA6, GRA4, and ROP7. As the CTL epitopes
defined for the previously reported three antigens are all H-2L
d-
restricted, this study is the first to characterize the CTL response to
a natural Toxoplasma antigen in C57BL/6 mice. Because the
C57BL/6 mouse strain is the most commonly used genetic
background for infectious disease and basic immunology research
[19], our discovery contributes an important tool for future
research on CD8+ T cell responses during toxoplasmosis. Tgd057
was originally characterized as a highly abundant expressed
sequence tag (EST) in T. gondii tachyzoites that is completely
unique to this parasite and homologues are not found in other
Apicomplexan organisms [36]. Notably, the nucleotide sequence
of tgd057 is completely identical amongst Type I, II and III strains
of T. gondii (www.toxodb.org/toxo/). Using purified polyclonal
anti-tgd057 Abs, we analyzed the localization of tgd057 within the
parasite and found that it does not localize to the vacuolar lumen
nor the parasitophorous vacuolar membrane, as expected of -
secreted proteins. Instead, tgd057 remained largely detergent
insoluble, and appears to be associated with the parasite’s
cytoskeleton. Unlike GRA6 and GRA4, which localize to the
intravacuolar network, and ROP7, which traffics to the para-
sitophorous vacuole membrane, tgd057 staining remained largely
within the parasite. It is currently still unclear if tgd057 escapes the
parasitophorous vacuole and how processing and presentation of
tgd057 occurs. Nevertheless, our results indicate that T. gondii
antigens which serve as CTL targets do not necessarily have to be
secreted parasite proteins.
Tgd057-specific CTLs were activated during acute infection
initiated with either Toxoplasma tachyzoites or bradyzoites, and
after vaccination with live, irradiated parasites. Unlike ROP7- and
GRA6-specific CTLs, whose numbers peak at 4–6 weeks post-
infection with bradyzoites and correlate with the establishment of
chronic infection [16,17], tgd057-specific CTLs are induced at
high frequency on day 7 during acute infection (Figure 2),
suggesting that the tgd057 antigen is immediately available for
processing in antigen presenting cells. Phenotypically, tgd057-
specific effector CTLs were generally representative of the total
CD8+ T cell population and contained higher frequencies of cells
expressing granzyme B and IFN-c compared to the polyclonal
population. Similar to the immunodominant GRA6-specific CTLs
mediating L
d-restricted protective immunity in BALB/c mice
which represent 20% of the total CTL population and a presumed
majority of the IFN-c producers [16], tgd057-specific CTLs
probably also represent an immunodominant population repre-
senting approximately 10% of the total granzyme B+ effector CTL
population on day 8 post-vaccination (as shown in Figure 3, where
2.4% (i.e. 53% of 4.53% tetramer+ CTLs are granzyme B+)o f
CD8+ T cells are both positive for tetramer-binding and granzyme
B, whereas 29% of total CD8+ T cells have intracellular granzyme
B). Tgd057-specific CTLs (obtained from ES-cloned mice
following somatic cell nuclear transfer of individual nuclei from
tgd057-tetramer+ CD8+ T cells into ES cells) can mediate
significant protective immunity to lethal parasite challenge in
adoptive transfer recipients (O. Kirak et al. manuscript submitted),
suggesting that tgd057 is a protective CTL target antigen.
In light of previous reports demonstrating enhanced CTL
memory responses in the absence of IL-12 during viral and
bacterial infection [26,27], we asked to what extent IL-12 controls
memory CTL responses during parasite infection, given that IL-12
drives effector CTL differentiation in the primary response [22].
Using the memory CTL subpopulation distribution to gauge the
relative frequencies of TEM (CD62L
lo FII and FIII) and TCM
(CD62L
hi FI), we observed that IL-12 was required for the
KLRG1+ mature FIII TEM subset, but not for the KLRG1- FI
(TCM) and FII (TEM) subsets. Furthermore, in mice transiently
depleted of IL-12 during the primary response and in mice
genetically deleted of IL-12, the resultant TEM were incapable of
mounting IFN-c recall responses to parasite rechallenge. This
indicates that IL-12 signaling during the primary CTL activation
initiates a long-lasting effector program, including both IFN-c
production and KLRG1+ FIII subset differentiation. This
program is imprinted on TEM and cannot be recovered in the
presence of IL-12 during the secondary response. The imprinting
effect of IL-12, produced during primary CTL activation, on the
effector competence of TEM is consistent with previous in vitro
experiments indicating that only a brief window of Ag/
costimulation exposure is needed to initiate CTL clonal expansion
[46] and that IL-12 stimulation for 30–60 hours in vitro is enough
to program optimal effector function in Ag/B7-activated CTLs
[47]. To our knowledge, our study is the first to clearly
demonstrate effector imprinting by IL-12 in CD8+ effector
memory T cells formed in response to microbial infection, an
effect that may have been masked in viral and bacterial infection
systems, due to the production of multiple and redundant ‘‘signal
3’’ cytokines and to the common practice of using peptide-
pulsed rather than naturally-infected antigen presenting cells for
restimulation.
The difference in the IFN-c responses of IL-12-deficient CTLs
when restimulated with infected cells versus cognate peptide
remains somewhat puzzling. Because the tgd057-peptide dose
responsiveness appears to be equivalent in CD8+ T cells
developing in the presence or absence of IL-12, it seems unlikely
that this difference is simply due to a lower level of antigenic
peptide display on infected cells. Whereas the short-term peptide
restimulation assay only queried the immediate capability of Ag-
specific CTLs to make IFN-c in response to TCR ligation, the
precise contribution of TCR- and cytokine-driven IFN-c produc-
tion during the longer parasite restimulation assay is still unclear.
Perhaps during the longer period required for the parasite
restimulation, a second IL-12-dependent phase of stable IFN-c
production dominates.
It will be interesting to find out whether IL-27 receptor signaling
functions along the same pathway as IL-12, given the striking
defect in CD8+ T cell responses to T. gondii observed in IL-27R-
deficient mice [48]. The role of IL-12 in driving CD8+ T cell
effector and effector-memory differentiation which we describe
here and elsewhere [22], is strikingly analogous to the established
function of IL-12 in enhancing TH1 effector maturation [30,49]
and the recently delineated effect of IL-23 in TH17-mediated
inflammation [50]. In all cases, innate signaling does not
determine the cytokine phenotype of the T cell response per se.
Rather, IL-12/-23’s role is to ensure optimal expansion and to
drive and maintain the differentiated state of effector cells, such
that in their absence, effector cell development is stalled at an
earlier differentiation stage.
Although IL-12 plays a positive and protective role in driving
effector differentiation of primary-effector and effector-memory T
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IL-12 on the TCM compartment. The results presented in
Figures 6, 7, 8, and 9 clearly illustrated that IL-12 negative
impacts quantitative and qualitative aspects of the central memory
response. In Il12a
2/2 immune rested mice, the reduced frequency
of the KLRG1+ FIII subset was accompanied by the emergence of
FI as a prominent subset of peripheral memory CTLs (Figure 6B).
The prominence of FI in Il12a
2/2 immune PECs represents a
major qualitative shift in the resting pool of peripheral TEM and
TCM and suggests that IL-12 drives effector memory differentia-
tion at the cost of TCM development. In addition to the increased
incidence of FI cells, our adoptive transfer experiments (Figure 9)
revealed a greater proliferative potential of FI-type cells formed in
the absence of IL-12, manifesting as increased representation of
their descendants during a secondary adaptive immune response.
When responding under conditions with sufficient ambient IL-12,
FI cells derived from IL-12-deficient mice showed no defect in
their ability to generate a heterogenous population of competent
effector cells.
Precisely how IL-12 favors the differentiation of effector CD8+
T cells at the expense of central memory T cell or their precursors
remains unclear. The mechanism by which IL-12 regulates TCM
differentiation may be direct, assuming that at some point during
their early development, TCM precursors express IL-12 receptors.
Low level or transient IL-12 signaling in TCM precursors might
shift the balance of transcription factors that regulate effector
versus memory differentiation. Takemoto et al. demonstrated that
IL-12 induces T-bet while repressing Eomes in WT effector CTLs
[41]. Consequently, IL-12 deficiency during the initial priming
may result in greater Eomes expression among central memory
precursor CTLs. Eomes expression has been correlated with the
enhanced responsiveness of memory CTLs to cc-chain cytokines,
as the IL-2/IL-15Rb chain is a direct target of Eomes [51]. Hence,
TCM from IL-12-deficient mice may have enhanced homeostatic
proliferation due to IL-15-induced self-renewal. In addition, the
recently reported ability of IL-12 to enhance the stability of the
immunological synapse [52] may result in a greater frequency of
memory precursor T cells differentiating towards a terminally
differentiated KLRG1+ effector fate.
Two recent reports highlight a new role for the transcriptional
repressor Blimp-1 in the regulation of effector CD8+ T cell
terminal differentiation during viral infection. It was demonstrated
that CTL differentiation skewed toward TCM development in
Blimp-1-deficient mice [53,54]. As a consequence, these CD8+ T
cells lacked KLRG1 expression, effector molecule expression, and
cytolytic function - an effect reminiscent of IL-12-deficient CTLs.
Interestingly, primary Blimp-1
2/2 anti-influenza CTLs expressed
lower levels of T-bet transcripts and increased levels of Eomes and
Bcl6 transcripts [54]. Given that IL-12 signaling also induces T-bet
while repressing Eomes expression [41], it seems likely that IL-12
governs the expression of multiple transcription factors, including
Blimp-1, for the coordinate induction of the TC1 effector program.
However, what the current literature has lacked and what we now
show is IL-12’s influence extends beyond that of the terminal
effector cells, reaching into the memory precursor subpopulation
and negatively affecting memory function.
In summary, our results demonstrate that IL-12 signaling has an
‘‘antagonistically pleiotropic’’ effect on the development of effector
memory and central memory compartments of the adaptive CD8+
T cell response to an intracellular pathogen. By efficiently
promoting effector competence of CD8+ T cells to secrete
cytokines and express cytolytic molecules, IL-12 protects the
immunologically naive host against acute mortality caused by
uncontrolled parasite growth. Nevertheless, this beneficial effect
comes at a cost of limiting the reserve pool of memory T cells that
can respond to subsequent re-infections. This delicate balance
must be considered in the design and implementation of
vaccination strategies involving the use of IL-12 and other innate
cytokines as immunological adjuvants.
Materials and Methods
Mice and infection
Wild-type (WT) C57BL/6J, Il12a
2/2 (B6.129S1-Il12a
tm1Jm/J),
Thy1.1+ (B6.PL-Thy1
a/CyJ), and CD45.1+ (B6.SJL-Ptprc
a Pep
c/
BoyJ) mice were purchased from The Jackson Laboratory (Bar
Harbor, ME). Il12b
2/2 mice (C57BL/6NTac-[KO]IL12p40),
housed at Taconic Farms (Germantown, NY), were a gift from
Dragana Jankovic at the NIAID. All mice were housed under
specific pathogen-free conditions at the University of Medicine
and Dentistry of NJ (Newark, NJ) and were handled according to
UMDNJ Institutional Animal Care and Use Committee guide-
lines. Sex- and age-matched mice were used in all experiments.
Fresh T. gondii tachyzoites were isolated from infected
monolayers of human foreskin fibroblasts (HFFs) in culture. To
vaccinate against Toxoplasma,1 610
6 live, mutant tachyzoites were
i.p. injected into each mouse. These parasites (cps1-1 or CPS)
contain a disrupted carbamoyl phosphate synthetase (CPS) II
gene, and are avirulent due to the inability to synthesize uracil
[38]. In vitro, CPS cultures were grown in DMEM (Invitrogen,
Carlsbad, CA) supplemented with 1% FBS, 1% penicillin/
streptomycin (P/S), 1% L-glutamine, and 300 mM uracil. To
ensure that the CPS parasites do not revert to the virulent parental
strain (RH) in vivo, CPS parasites were irradiated (150 Gy) using a
137Cs source before injection. Natural Toxoplasma infection was
mimicked by peroral administration of brain cysts containing T.
gondii bradyzoites. On the day of infection, cysts were harvested
from the brains of C57BL/6 mice chronically infected with the
ME49 strain. Then, each mouse was gavaged with brain matter
containing 20 cysts. GFP-RH parasites were obtained from
American Type Culture Collection.
Epitope prediction and peptide synthesis
Primary amino acid sequence data from selected ORFs was
collected from the National Center for Biotechnology Information
(www.ncbi.nlm.nih.gov/) and the Toxoplasma gondii Genome
resource (www.toxodb.org/toxo/). The first and second screen
consisted of 6 and 73 ORFs, respectively, from which 96 and 384
H-2K
b-restricted 8-mer and H-2D
b-restricted 9-mer peptides were
predicted (Tables S1, S2 and S3) using a consensus epitope
prediction program [32,34]. The peptides identified for screening
were synthesized by the biopolymers facility at MIT CCR
(Cambridge, MA), whereas the conditional ligands were obtained
by manual solid-phase peptide synthesis using commercially
available Fmoc-protected amino acids as described earlier [34].
Quality assurance of the synthesis was provided by MALDI-TOF
mass spectrometry, after which the crude peptides were lyophi-
lized, taken up in DMSO (10 mg/mL), and kept at -20uC.
Generation of MHC class I tetramers for epitope
screening
Refolding of recombinantly expressed H-2K
b and H-2D
b
complexes holding the SV9-P7* conditional ligand, biotinylation
of the soluble MHC class I products and ensuing tetramerization
was performed according to published protocols. Peptide ex-
change was performed in a 96-well plate on ice using longwave
UV irradiation to replace the conditional ligand with cognate
peptide as described [34].
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Tgd057 cDNA (accession AY313956) was subcloned into the
BamH1 site of pQE-60 bacterial expression vector containing a C-
terminal 6xHis tag (QIAGEN). The tgd057 expression vector was
transduced into E. coli XL1 blue supercompetent cells and tgd057
protein was induced by the addition of 1 mM Isopropyl-b-D-
thiogalactoside. After 4 hours of induction recombinant tgd057
protein was harvested from the bacteria, purified by Ni-NTA
affinity chromatography, and subsequently dialyzed to remove
contaminating molecules, all according to the manufacturer’s
instructions (QIAGEN). The expression of tgd057 was detected by
western blotting with anti-His mAbs and coomassie blue staining.
Tgd057 antiserum was commercially generated by immunizing
rabbits with 2 doses of 0.5 mg recombinant tgd057 over 2 months
(Cocalico Biologicals, Reamstown, PA).
About 180 mg of purified recombinant tgd057 protein was
further fractionated by SDS-PAGE. Protein was transferred to
PVSF membrane, and then stained with Porcean S for 5 min
followed by 2 washes in distilled water with gentle shaking. The
tgd057 protein band, dominantly displayed at a MW of about
23 kDa, was cut from the membrane. The membrane strip was
blotted with 200 mL anti-tgd057 serum in 20 mL PBS with 3%
BSA and 0.05% Tween-20 overnight at 4 degrees C. Anti-tgd057
Abs were stripped by incubating the membrane strip with 5 mL of
100 mM glycine, pH 2.6 for 2 min. The specificity of the purified
antibodies was confirmed by comparison with anti-His mAbs in
detecting recombinant tgd057 using a western blot.
Western blot
Two flasks of HFFs were inoculated with CPS parasites. Two
days later, parasites were harvested just before HFF lysis. Infected
HFFs were scraped and lysed by needle passage. After centrifu-
gation, the resultant pellet from one flask (HFF+CPS) was
resuspended in 100 mL lysis buffer (Modified RIPA Buffer:
50 mM Tris-HCl, pH 7.4 + 1% NP-40 + 0.25% Na-deoxycholate
+ 150 mM NaCl + 1 mM EDTA). The pellet from the other flask
was vigorously resuspended and incubated in 100 mL 1% Triton
X-100 in PBS on ice for 15 min. For the negative control, one
flask of uninfected HFFs (HFF-CPS) was harvested and resus-
pended in 100 mL mRIPA buffer. All lysates were then centrifuged
at 10,000 rcf for 15 min. The resultant supernatants were removed
and transferred to a new tube. All pellets were resuspended in
100 mL modified RIPA buffer. 20 mL of each sample was
separated on 4–12% Ready Gel precast gels (BIO-RAD, Hercules,
CA) followed by transfer onto PVSF membrane. The membrane
was blotted with anti-tgd057 rabbit Abs at a dilution of 1:100.
Following washing, the blot was incubated with goat anti-rabbit
secondary Abs (Invitrogen) for 45 minutes at room temperature.
Bands were visualized using LumiGOLD ECL detection kit
(SignaGen Laboratories, Ijamsville, MD), followed by exposure to
X-ray film.
Immunofluorescence staining and microscopy
HFFs attached to microscope coverslips were infected with
parasites in vitro for 30 min at 37uC. Extracellular parasites were
subsequently washed out and the infected cells were incubated in
DMEM culture medium + 1% FBS, 1% P/S at 37uC. After
incubation, the HFFs were fixed (4% formaldehyde in PBS) for
15 min at RT. HFFs were then incubated in blocking buffer (PBS
+ 3% BSA, 0.2% saponin) for 60 min at RT while shaking.
Primary Abs were diluted in blocking buffer and incubated with
HFFs for 60 min at RT followed by extensive washing. HFFs were
similarly stained with goat anti-rabbit IgG-AlexaFluor-568
secondary Abs (Invitrogen) for 45 min at RT. Coverslips were
then mounted on microscope slides with ProLong Gold antifade
reagent with DAPI (Invitrogen). Images were acquired on a Zeiss
Axiovert 200 M fluorescent microscope and analyzed using
AxioVision Rel 4.6 software.
Tissue preparation and in vitro restimulation
Peritoneal exudates cells (PECs) were isolated by peritoneal
lavage with RPMI 1640 (Invitrogen) supplemented with 2% FBS,
1% P/S, and 50 mM b-mercaptoethanol. Splenocytes were
harvested by physical disruption of the spleen and passage through
a7 0mM nylon mesh. The protocol for brain mononuclear cell
isolation was kindly provided by Yasuhiro Suzuki. Briefly, brains
were perfused with PBS, excised from the mouse and physically
disrupted to free the mononuclear cells. Mononuclear cells were
isolated by centrifugation in 35% Percoll (GE Healthcare,
Piscataway, NJ) solution overlayed on pure FBS. Live cells were
counted in a hemacytometer by trypan blue exclusion.
To restimulate the cells, samples were plated in 48-well TC-
treated plates in RPMI Complete medium (RPMI 1640 + 10%
FBS, 1% P/S, 50 mM b-mercaptoethanol) and inoculated with
live CPS parasites (MOI=0.1). CPS restimulated samples
were incubated for 10 hours at 37uC with the addition of
GolgiStop (BD Biosciences, San Jose, CA) for the last 4 hours.
SVLAFRRL and SIINFEKL peptides were synthesized in house
at the UMDNJ Molecular Resource Facility. For peptide
restimulations, samples were plated in 96-well TC-treated plates
in RPMI Complete medium. Unless otherwise noted, freshly
thawed peptides were added at a final concentration of 10
210
M. Peptide restimulated samples were incubated for 6 hours at
37uC with the addition of GolgiStop for the last 4 hours. To
induce detectable IL-2 expression by flow cytometry, samples
were restimulated with PMA (50 ng/mL) and ionomycin
(500 ng/mL) for 6 hours at 37uC with the addition of GolgiStop
for the last 4 hours.
Abs and tetramer staining
Cell surface Ab and tetramer staining was performed simulta-
neously in FACS Buffer (1XPBS + 1% BSA, 0.05% NaN3) for
1 hour on ice. The cells were then fixed in 100 mL BD Cytofix for
20 min on ice. For intracellular staining, Abs were diluted in BD
Perm/Wash buffer and samples were stained for 30 min on ice.
Fixed samples were resuspended in FACS Buffer and analyzed on
either a BD FACS Calibur or BD LSRII flow cytometer. Flow
data was analyzed using FlowJo (Tree Star, Ashland, OR). Mouse-
specific Abs obtained from BD Biosciences: CD62L (MEL-14),
CD45.2 (104). Mouse-specific Abs obtained from eBioscience (San
Diego, CA): CD44 (IM7), IFN-c (XMG1.2), CD3e (145.2C11),
CD8a (53-6.7), CD90.2 (53.2.1), CD127 (A7R34), TCRb (H57-
597), KLRG1 (2F1), IL-2 (JES6-5H4). Anti-human Granzyme B
(GB11) was obtained from CALTAG Laboratories (Invitrogen,
Carlsbad, CA).
In vivo IL-12p40 neutralization
On day 0, each mouse was i.p. injected with 1 mg of either anti-
IL-12p40 mAb (C17.8) or an isotype control (2A3) (BioXCell,
West Lebanon, NH). After ,4 hours mice were vaccinated with
irradiated, CPS parasites. On day 3 post-vaccination mice were
given another 1 mg dose of mAb.
Sorting and adoptive transfer
CD8+ T cells were negatively selected from immune WT
CD45.1 congenic and immune Il12a
2/2 spleens using magnetic
microbeads (Miltenyi Biotec, Auburn, CA). WT and Il12a
2/2
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KLRG1. Stained samples were then sorted for CD44
hi FI+
(CD62L
hi KLRG1-) cells using a BD FACS Vantage cell sorter. In
a separate pre-sorted sample, WT and Il12a
2/2 immune CD8+ T
cells were stained for tetramer positivity within fractions in ex vivo
immune splenocytes. The frequency of tetramer+ cells in FI
immune CD8+ T cells was used to normalize the numbers of
predicted tetramer+ cells in sorted samples. WT and Il12a
2/2 FI
CD8+ T cells were mixed and i.v. injected (retro-orbital) into naı ¨ve
WT CD90.1 congenic recipient mice.
Supporting Information
Figure S1 Absolute cell numbers of tgd057-specific CTLs
generated by either vaccination or natural infection. The absolute
cell numbers of CD44
hi K
b/SVLAFRRL+ CD8a+ TCRb+ cells
was calculated for samples corresponding to the groups in Figure 2.
Values are mean 6 SEM of three mice except for the Acute ME49
PECs, which is a pooled sample from three mice.
Found at: doi:10.1371/journal.ppat.1000815.s001 (0.15 MB TIF)
Figure S2 The effect of IL-12 addback on WT and IL-12-
deficient CTLs during ex vivo CPS restimulation. PECs and
spleens were harvested from day 8 (D8) CPS-primed WT and
Il12b
2/2 mice. Spleens were also taken from naive WT mice to
serve as negative controls. WT and Il12b
2/2 PECs and
splenocytes were then restimulated under five different conditions
for 10 hours. Blue, unstimulated cultures were left unadulterated.
Green,‘ ‘ +CPS +Isotype’’ cultures contained CPS parasites at MOI
of 0.1 and 20 mg of rat IgG2a isotype Ab. Yellow,‘ ‘ +CPS +anti-IL-
12’’ cultures contained CPS parasites at MOI of 0.1 and 20 mgo f
anti-IL-12p40 mAb. Red,‘ ‘ +CPS +rIL-12’’ cultures contained
CPS parasites at MOI of 0.1 and at three hours post-addition of
parasites 1 ng rIL-12p70 was added. Purple, ‘‘rIL-12’’ cultures
contained 1 ng rIL-12p70 added at three hours post-incubation.
Values represent mean 6 SEM of three mice.
Found at: doi:10.1371/journal.ppat.1000815.s002 (0.54 MB TIF)
Table S1 Manually curated list of sequences obtained from
National Center for Biotechnology Information (www.ncbi.nlm.
nih.gov/) and the Toxoplasma gondii Genome resource (www.
toxodb.org/toxo/) for putative secreted proteins derived from
Toxoplasma gondii. The predicted H-2K
b-restricted octameric and
H-2D
b-restricted nonameric epitopes are highlighted in gray. The
N-terminal residue of the individual epitopes is highlighted in
black to discriminate overlapping sequences. Highlighted in red is
the H-2K
b-restricted epitope identified to give a CD8
+ T cells
response in C57BL/6 mice.
Found at: doi:10.1371/journal.ppat.1000815.s003 (0.16 MB
DOC)
Table S2 The 48 and 192 highest scoring H-2K
b-restricted
octameric epitopes as assayed in screens 01 and 02, respectively.
The epitopes were derived from putative secreted proteins of
Toxoplasma gondii. Predictions were performed using a consensus
epitope prediction algorithm. The program, including documen-
tation for its execution and sample data, is freely available at
http://jura.wi.mit.edu/bioc/grotenbreg. The epitope identified to
give a CD8
+ T cells response in B6 mice is highlighted in red.
Found at: doi:10.1371/journal.ppat.1000815.s004 (0.62 MB
DOC)
Table S3 The 48 and 192 highest scoring H-2D
b-restricted
nonameric epitopes as assayed in screens 01 and 02, respectively.
The epitopes were derived from putative secreted proteins of
Toxoplasma gondii. Predictions were performed using a consensus
epitope prediction algorithm. The program, including documen-
tation for its execution and sample data, is freely available at
http://jura.wi.mit.edu/bioc/grotenbreg.
Found at: doi:10.1371/journal.ppat.1000815.s005 (0.63 MB
DOC)
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